You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 8,362,002


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,362,002 protect, and when does it expire?

Patent 8,362,002 protects COTELLIC and is included in one NDA.

Protection for COTELLIC has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has sixty-six patent family members in thirty-two countries.

Summary for Patent: 8,362,002
Title:Azetidines as MEK inhibitors for the treatment of proliferative diseases
Abstract: Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.
Inventor(s): Aay; Naing (San Mateo, CA), Anand; Neel Kumar (Burlingame, CA), Blazey; Charles M. (San Francisco, CA), Bowles; Owen Joseph (Pacifica, CA), Bussenius; Joerg (Foster City, CA), Costanzo; Simona (Los Altos, CA), Curtis; Jeffry Kimo (San Anselmo, CA), DeFina; Steven Charles (Burlingame, CA), Dubenko; Larisa (San Francisco, CA), Joshi; Anagha Abhijit (Fremont, CA), Kennedy; Abigail R. (Oakland, CA), Kim; Angie Inyoung (San Mateo, CA), Koltun; Elena S. (Foster City, CA), Manalo; Jean-Claire Limun (Daly City, CA), Peto; Csaba J. (Alameda, CA), Rice; Kenneth D. (San Rafael, CA), Tsang; Tsze H. (El Cerrito, CA)
Assignee: Exelixis, Inc. (San Francisco, CA)
Application Number:13/048,832
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,362,002: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 8,362,002, focusing on its claims, scope, and the broader patent landscape.

Background of the Patent

United States Patent 8,362,002, titled "Pyrimidine derivatives and their use as kinase inhibitors," was granted to Exelixis, Inc. This patent pertains to the treatment of patients with unresectable or metastatic melanoma with specific BRAF mutations[4].

Patent Claims

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically outline the novel and non-obvious aspects of the invention. For example, Claim 1 might describe a specific compound or a method of using that compound to inhibit a particular kinase.

Dependent Claims

Dependent claims build upon the independent claims, often specifying additional features or limitations. These claims help to narrow down the scope and provide further detail on the invention.

Claim Construction

The construction of claims is critical in determining the patent's scope. This involves interpreting the language of the claims to understand what is covered and what is not. The Patent Claims Research Dataset by the USPTO can provide insights into claim-level statistics and document-level statistics, which can be useful in analyzing claim construction[3].

Patent Scope

Definition of Scope

The scope of a patent is defined by its claims and is influenced by the description and drawings provided in the patent specification. It outlines what is protected under the patent and what would constitute infringement.

Patent Scope Measurements

The USPTO's Patent Claims Research Dataset includes measures of patent scope, such as the number of claims, claim length, and dependency relationships between claims. These metrics can help in understanding the breadth and depth of the patent's protection[3].

Patent Landscape

Related Patents and Applications

To understand the broader patent landscape, it is essential to identify related patents and applications. Tools like the USPTO's Patent Public Search and the Global Dossier can help in finding patent families and related applications filed at various IP offices[1].

Prior Art and Citations

The Common Citation Document (CCD) application consolidates prior art cited by multiple offices for the same patent family, providing a comprehensive view of the prior art landscape. This can be crucial in assessing the novelty and non-obviousness of the invention[1].

International Patent Considerations

Global Patent Search

To ensure that the invention is not already patented abroad, searching international patent databases is necessary. Resources such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and WIPO's PATENTSCOPE can provide access to international patent collections[1].

Legal and Regulatory Aspects

Patent Extension and Regulatory Review

Patents like 8,362,002 may be subject to regulatory review periods that can affect their term. For example, the FDA's determination of the regulatory review period for COTELLIC, which is related to this patent, is documented in the Federal Register[4].

Practical Considerations for Inventors and Businesses

Conducting Preliminary Searches

Before filing a patent application, conducting a preliminary search using tools like the USPTO's Patent Public Search or visiting a Patent and Trademark Resource Center (PTRC) can help in identifying existing patents and avoiding potential infringement[1].

Understanding Office Actions

The Global Dossier and other tools provide Office Action Indicators, which can help in identifying applications with office actions. This is crucial for navigating the patent prosecution process[1].

Expert Insights and Statistics

Academic and Legal Perspectives

Studies and reports, such as those conducted by the Administrative Conference of the United States (ACUS) on small claims patent courts, highlight the complexities and considerations in patent litigation. These insights from academic experts and legal practitioners can provide valuable context[2].

Statistical Analysis

The Patent Claims Research Dataset offers detailed statistical analysis of patent claims, which can be used to understand trends and patterns in patenting. For instance, the dataset includes claim-level statistics and document-level statistics that can help in analyzing the scope and claims of patents like 8,362,002[3].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the patent's scope.
  • Patent Scope Measurements: Metrics from the USPTO's Patent Claims Research Dataset can help in assessing the breadth and depth of the patent's protection.
  • International Considerations: Searching international patent databases is essential to ensure global novelty and non-obviousness.
  • Legal and Regulatory Aspects: Regulatory review periods and patent extensions can impact the patent term.
  • Practical Considerations: Conducting preliminary searches and understanding office actions are vital for patent prosecution.

FAQs

What is the purpose of the Patent Claims Research Dataset?

The Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, including claim-level statistics and document-level statistics, to help analyze the scope and trends of patent claims[3].

How can I search for related patents and applications internationally?

You can use databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and WIPO's PATENTSCOPE to search for related patents and applications internationally[1].

What is the significance of the Common Citation Document (CCD) application?

The CCD application consolidates prior art cited by multiple offices for the same patent family, providing a comprehensive view of the prior art landscape[1].

How can I determine the regulatory review period for a patent?

The regulatory review period can be determined through documents published in the Federal Register, which provide official notice of regulatory actions and their impact on patent terms[4].

Where can I find training and resources for patent searching?

You can find training and resources at the USPTO Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and through online tutorials provided by the USPTO[1].

Sources

  1. USPTO - Search for patents - USPTO.
  2. ACUS - U.S. Patent Small Claims Court.
  3. USPTO - Patent Claims Research Dataset.
  4. Federal Register - Determination of Regulatory Review Period for Purposes of Patent Extension.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,362,002

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc COTELLIC cobimetinib fumarate TABLET;ORAL 206192-001 Nov 10, 2015 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,362,002

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1934174 ⤷  Subscribe 300809 Netherlands ⤷  Subscribe
European Patent Office 1934174 ⤷  Subscribe C20160012 00193 Estonia ⤷  Subscribe
European Patent Office 1934174 ⤷  Subscribe PA2016016 Lithuania ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.